Trial updateRetina
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Recruiting. Phase 2. Registered enrolment: 160. EyeBiotech Ltd.
Why it matters
Track this study through NCT07205887. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 2
- Registered enrolment
- 160
- Results posted
- No
- Sponsor
- EyeBiotech Ltd.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.